These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23167796)

  • 21. CNS leptin and insulin action in the control of energy homeostasis.
    Belgardt BF; Brüning JC
    Ann N Y Acad Sci; 2010 Nov; 1212():97-113. PubMed ID: 21070248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central infusion of ketone bodies modulates body weight and hepatic insulin sensitivity by modifying hypothalamic leptin and insulin signaling pathways in type 2 diabetic rats.
    Park S; Kim DS; Daily JW
    Brain Res; 2011 Jul; 1401():95-103. PubMed ID: 21652033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rethinking leptin and insulin action: therapeutic opportunities for diabetes.
    Yildiz BO; Haznedaroglu IC
    Int J Biochem Cell Biol; 2006; 38(5-6):820-30. PubMed ID: 16236542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.
    DeFronzo RA; Davidson JA; Del Prato S
    Diabetes Obes Metab; 2012 Jan; 14(1):5-14. PubMed ID: 21955459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.
    Porte D; Kahn SE
    Am J Med; 1991 Jun; 90(6A):8S-14S. PubMed ID: 1872310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic drugs in type 2 diabetes and glucose homeostasis.
    Lopez Vicchi F; Luque GM; Brie B; Nogueira JP; Garcia Tornadu I; Becu-Villalobos D
    Pharmacol Res; 2016 Jul; 109():74-80. PubMed ID: 26748034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?
    Ampofo E; Nalbach L; Menger MD; Montenarh M; Götz C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term obestatin treatment of mice type 2 diabetes increases insulin sensitivity and improves liver function.
    Kołodziejski PA; Pruszyńska-Oszmałek E; Strowski MZ; Nowak KW
    Endocrine; 2017 Jun; 56(3):538-550. PubMed ID: 28477305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans.
    Porte D; Baskin DG; Schwartz MW
    Diabetes; 2005 May; 54(5):1264-76. PubMed ID: 15855309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The glucoregulatory actions of leptin.
    D'souza AM; Neumann UH; Glavas MM; Kieffer TJ
    Mol Metab; 2017 Sep; 6(9):1052-1065. PubMed ID: 28951828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.
    Kalra SP
    Peptides; 2009 Oct; 30(10):1957-63. PubMed ID: 19647774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A; Nafees B; Barnett AH; Heller S; Ploug UJ; Lammert M; Bøgelund M
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats.
    Zhou J; Zhang J; Luo X; Li M; Yue Y; Laudon M; Jia Z; Zhang R
    Eur J Pharmacol; 2017 Oct; 812():225-233. PubMed ID: 28687198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A ketogenic diet impairs energy and glucose homeostasis by the attenuation of hypothalamic leptin signaling and hepatic insulin signaling in a rat model of non-obese type 2 diabetes.
    Park S; Kim DS; Kang S; Daily JW
    Exp Biol Med (Maywood); 2011 Feb; 236(2):194-204. PubMed ID: 21321316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The central nervous system at the core of the regulation of energy homeostasis.
    Luquet S; Magnan C
    Front Biosci (Schol Ed); 2009 Jun; 1(2):448-65. PubMed ID: 19482713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of paradoxical observations on the association between leptin and insulin resistance.
    Ceddia RB; Koistinen HA; Zierath JR; Sweeney G
    FASEB J; 2002 Aug; 16(10):1163-76. PubMed ID: 12153984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leptin, 20 years of searching for glucose homeostasis.
    Fernández-Formoso G; Pérez-Sieira S; González-Touceda D; Dieguez C; Tovar S
    Life Sci; 2015 Nov; 140():4-9. PubMed ID: 25744051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule activators of the insulin receptor: potential new therapeutic agents for the treatment of diabetes mellitus.
    Laborde E; Manchem VP
    Curr Med Chem; 2002 Dec; 9(24):2231-42. PubMed ID: 12470244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.